Abbott India Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Total operating expenditure for the period under review was Rs 1,228.66 crore, up 4.5% YoY.

Profit before tax in Q4 FY26 stood at Rs 531.23 crore, up by 10.1% from Rs 482.71 crore in Q4 FY25.

For FY26, the company has recorded net profit and revenue from operations of Rs 1552.02 crore (up 9.7% YoY) and Rs 6,929.05 crore (up 8.1% YoY), respectively.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

The scrip fell 1.99% to currently trade at Rs 27224.40 on the BSE.

Powered by Capital Market - Live News

Abbott India announced that the Board of Directors of the Company at its meeting held on 11 May 2026, inter alia, have recommended the special dividend of Rs 131 per equity Share (i.e. 1310%) , subject to the approval of the shareholders.

Abbott India announced that the Board of Directors of the Company at its meeting held on 11 May 2026, inter alia, have recommended the final dividend of Rs 525 per equity Share (i.e. 5250%) , subject to the approval of the shareholders.

Abbott India announced that the 82th Annual General Meeting(AGM) of the company will be held on 13 August 2026.